Propanc Biopharma, Inc. Common Stock (PPCB) — Strategic Asset Allocation Index
Propanc Biopharma, Inc. Common Stock (PPCB) has a Strategic Asset Allocation Index of 0.3% as of March 2012. Strategic assets (PP&E of $5.00K plus long-term investments of $-) total $5.00K, measured against net assets of $1.68 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for Propanc Biopharma, Inc. Common Stock (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for Propanc Biopharma, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Propanc Biopharma, Inc. Common Stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|